Dataset of acute repeated sessions of bifrontal transcranial direct current stimulation for treatment of intractable tinnitus: A randomized controlled trial by Yadollahpour, A. et al.
Contents lists available at ScienceDirect
Data in Brief
Data in Brief 15 (2017) 40–46http://d
2352-34
(http://c
⁎ Corr
Science
E-mjournal homepage: www.elsevier.com/locate/dibData ArticleDataset of acute repeated sessions of bifrontal
transcranial direct current stimulation for
treatment of intractable tinnitus: A randomized
controlled trial
Ali Yadollahpour a,b,⁎, Arash Bayat c,d, Samaneh Rashidi a,b,
Nader Saki d, Majid Karimi e
a Department of Medical Physics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences,
Ahvaz, Iran
b Bioelectromagnetic Clinic, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences,
Ahvaz, Iran
c Musculoskeletal Rehabilitation Center, School of Rehabilitation, Ahvaz Jundishapur University of Medical
Sciences, Ahvaz, Iran
d Hearing Research Center, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences,
Ahvaz, Iran
e Department of Audiology, Iran University of Medical Sciences, Tehran, Irana r t i c l e i n f o
Article history:
Received 21 June 2017
Received in revised form
31 July 2017
Accepted 8 September 2017
Available online 13 September 2017
Keywords:
Transcranial direct current stimulation
Acute stimulations
Tinnitus
Depression
Anxiety
DLPFCx.doi.org/10.1016/j.dib.2017.09.006
09/& 2017 The Authors. Published by Elsev
reativecommons.org/licenses/by/4.0/).
esponding author at: Department of Medi
s, Ahvaz, Iran.
ail address: yadollahpour.a@gmail.com (A.a b s t r a c t
Transcranial direct current stimulation (tDCS) has reportedly
shown promising therapeutic effects for tinnitus (Forogh et al.,
2016; Joos et al., 2014) [1,2]. Studies are ongoing to determine
optimum treatment protocol and the site of stimulation. Findings
of the early studies are heterogeneous and most studies have
focused on single session tDCS and short follow-up periods. There
is no study on repeated sessions of tDCS with long term follow-up.
This study presents the results of a randomized clinical trial
investigating the therapeutic effects of acute multi-session tDCS
over dorsolateral prefrontal cortex (DLPFC) on tinnitus symptoms
and comorbid depression and anxiety in patients with chronic
intractable tinnitus. The dataset includes the demographic infor-
mation, audiometric assessments, tinnitus speciﬁc characteristics,
and the response variables of the study. The response variables
included the scores of tinnitus handicap inventory (THI), tinnitusier Inc. This is an open access article under the CC BY license
cal Physics, School of Medicine, Ahvaz Jundishapur University of Medical
Yadollahpour).
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A. Yadollahpour et al. / Data in Brief 15 (2017) 40–46 41loudness and tinnitus related distress based on 0–10 numerical
visual analogue scale (VAS) scores, beck depression inventory
(BDI-II) and beck anxiety inventory (BAI) scores. The dataset
included the scores of THI pre and immediately post intervention,
and at one month follow-up; the tinnitus loudness and distress
scores prior to intervention, and immediately, one hour, one week,
and at one month after the last stimulation session. In addition, the
BDI-II, and BAI scores pre and post intervention are included. The
data of the real (n¼25) and sham tDCS (n¼17) groups are repor-
ted. The main manuscript of this dataset is "Acute repeated ses-
sions of bifrontal transcranial direct current stimulation for treat-
ment of intractable tinnitus: a randomized controlled trial" (Bayat
et al., submitted for publication) [3].
& 2017 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Medicine
ore speciﬁc
subject areaNeurosciences and Otolaryngology, tinnitusype of data Tables
ow data was
acquiredAudiometric assessments, clinical examinations, questionnaires including
Tinnitus handicap inventory, numerical 0–10 visual analogue scale, Beck
depression inventory (BDI-II) and beck anxiety inventory (BAI)ata format Raw, processed data, biosignals.
xperimental
factorsA double blind randomized placebo controlled clinical trial investigated the
therapeutic effects of acute multi-session tDCS on tinnitus symptoms and
comorbid depression and anxiety in tinnitus patients with one month follow-up.xperimental
featuresAuditory and clinical assessments were performed. Response variables were
assessed prior intervention. The two groups of patients underwent real tDCS
(n¼25) and sham tDCS (n¼17) consisting twice daily for 5 consecutive days
(10 sessions) over DLPFC. After intervention the data were collected using
different questionnaires up to one month follow-up.ata source
locationImam Khomeini Hospital, Ahvaz, Iran, 31°18'11.5"N 48°44'41.9"Eata accessibility All of the data presented in this study are accessible within this article.Value of the data
 Data presented in this paper are collected from a double blind randomized placebo controlled
clinical trial with one month follow-up.
 This dataset presents the data on the effects of acute multisession tDCS on intractable chronic
tinnitus with one month follow-up.
 The data consist of the tDCS effects on THI, tinnitus loudness and distress, as well as comorbid
depression and anxiety as well as comprehensive demographic information, tinnitus character-
istics and audiometric assessment.
 Using these data other researchers can perform advanced statistical analyses and modeling to shed
more light on the efﬁcacy and nature of tDCS efﬁcacy in tinnitus treatment.
 The data can be used to develop treatment response predicting indexes.
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The data of this study were collected from a double blind randomized placebo controlled clinical
trial investigated the therapeutic efﬁcacy of tDCS in intractable chronic tinnitus (n¼42). The data
consist of two main categories including demographic information, tinnitus characteristics, and
audiometric assessments of the patients and the second group data are the values of response
variables at prior intervention and post intervention. The Tables 1 and 2 respectively present the
demographic information, tinnitus characteristics, and audiometric assessments of the participants in
the real tDCS and sham tDCS groups. Table 3 presents the response variables for prior and post
treatment for the real tDCS. Table 4 represents these measures for the sham tDCS. For this group, only
those patients who reported signiﬁcant outcome in the last assessment were followed up.2. Experimental design, materials and methods
2.1. Study design
In a double blinded randomized controlled clinical trial, patients with chronic intractable tinnitus
(n¼42) were divided into two groups of real (females (F)¼14, males (M)¼11, age: 46.6876.87 years,
disease duration: 7.872.84 years), and sham tDCS (F¼9, M¼8, age: 47.5377.56 years, disease
duration: 8.1172.8 years). Both groups were matched for age, gender, ethnicity, and audiometricTable 1
Demographic information, tinnitus characteristics, and audiometric assessments of the participants in the real tDCS.
Patient Age, y Sex Qualitya Lateralityb Duration(y) Hearing loss
right/leftc
1 44 M R R 8 N/L
2 43 M P R4L 5 L/N
3 48 M T RoL 12 M/L
4 51 M HPW L 11 M/L
5 54 M R R 6 L/N
6 38 M R R¼L 3 N/L
7 57 M P R4L 7 M/N
8 47 M H R 7 N/N
9 56 M HPW R 12 L/L
10 53 M B L 8 N/L
11 34 M R R 12 L/L
12 46 F HPW R 10 N/L
13 42 F H R¼L 5 N/N
14 47 F P L 11 P/M
15 39 F B LoR 5 L/L
16 48 F H U R 8 M/L
17 46 F B L 10 N/M
18 33 F H R¼L 9 N/N
19 43 F P R 6 N/N
20 45 F R R 4 N/N
21 60 F R R4L 12 N/M
22 50 F R R4L 7 L/L
23 55 F H R¼L 8 M/L
24 46 F B R 5 L/P
25 42 F R R 4 L/N
Note: THI, Tinnitus Handicap Inventory.
a Tinnitus Quality codes: R, ringing; B, buzzing; H, hissing; T, ticking; HPW, high pitch whistling; P, pulsating.
b Tinnitus side: L, left; R, right, R¼L, bilateral with no lateralization; R4L, bilateral lateralizing more to the right side; L4R,
bilateral lateralizing more to the left side.
c Class of hearing loss; N normal hearing threshold (o20 dB), L mild hearing loss (20–40 dB), M moderate hearing loss
(41–70 dB), S severe hearing loss (70–90 db), P profound hearing loss (490 db).
Table 2
Demographic information, tinnitus characteristics, and audiometric assessments of the participants in the sham tDCS.
No. Age, y Sex Qualitya Lateralityb Duration (y) Hearing loss right/leftc
1 55 F HPW R 10 P/L
2 43 F P L 6 N/L
3 47 F RþT L 9 M/N
4 63 F HPW RoL 8 L/M
5 48 F R R4L 4 N/L
6 42 F R R 9 N/N
7 38 F P R 7 N/N
8 54 F RþH R¼L 6 L/N
9 55 F P R 12 M/L
10 33 M R L 10 N/N
11 48 M P L 12 P/M
12 43 M HPW L 9 M/M
13 42 M R RoL 5 L/N
14 47 M HþB R 6 M/L
15 57 M T R4L 10 L/M
16 50 M H R 3 N/L
17 43 M R R4L 12 L/M
Note: THI, Tinnitus Handicap Inventory.
a Tinnitus Quality codes: R, ringing; B, buzzing; H, hissing; T, ticking; HPW, high pitch whistling; P, pulsating.
b Tinnitus side: L, left; R, right, R¼L, bilateral with no lateralization; R4L, bilateral lateralizing more to the right side; L4R,
bilateral lateralizing more to the left side.
c Class of hearing loss; N normal hearing threshold (o20 dB), L mild hearing loss (20–40 dB), M moderate hearing loss
(41–70 dB), S severe hearing loss (70–90 db), P profound hearing loss (490 db)
A. Yadollahpour et al. / Data in Brief 15 (2017) 40–46 43main characteristics. To reduce the procedure and subjective bias, the patients, the researchers who
collected the data, and the researchers who performed statistical analyses and interpretations were
blinded on the type of protocol. Before the intervention, the patients underwent complete audio-
metric and neurologic examinations by experienced specialists. The experimental procedures of the
present study including tDCS sessions, outcomes evaluations were performed in the Bioelec-
tromagnetic Clinic in Ahvaz Imam Hospital, an afﬁliated Hospital to Ahvaz Jundishapur University of
Medical Sciences (AJUMS), Iran. All of the experimental procedures of this study were approved by
the local ethics committee of AJUMS, Ahvaz, Iran (registration code: IR.AJUMS.REC.1394.639) which
were in accordance with the ethical standards and regulations of human studies of the Helsinki
declaration (2014) [4]. All participants ﬁlled and signed a written consent form for contribution in the
study following a clearly description of the experimental procedures, the objectives, possible beneﬁts,
and side effects of the study to the patients. The study was registered as a clinical trial in the Iranian
registry of clinical trials (IRCT2016110124635N5).
2.2. Hearing assessment
Pure-tone audiometry was performed using AC 40 dual channel Audiometer (Intracoustics Co.,
Denmark). The hearing thresholds were recorded over the frequency ranges of 250 to 8000 Hz for air
conduction and 500 to 4000 Hz for bone conduction pathways, using the modiﬁed Hughson–Wes-
tlake Method as recommended by ANSI 2005 [5]. Pure-tone audiometry was considered normal when
the hearing thresholds at all frequencies were below 20 dBHL. Hearing loss was classiﬁed according to
the type and degree [6].
2.3. tDCS intervention
The tDCS was performed through carbon electrodes embedded in a saline-soaked pair of sponges
(35 cm2) and delivered by a battery-driven, constant current stimulator with a maximum output of
4 mA (OASIS Pro™ device by Mind Alive Inc., Edmonton, Alberta, Canada). The real tDCS consisted of
Table 3
The response variables for prior and post treatment for the real tDCS.
THI Loudness Distress BDI BAI
Pre Post Post-1m Pre Post-i Post-1h Post-1w Post-1m Pre Post-i Post-1h Post-1w Post-1m Pre Post Pre Post
67 40 44 8 5 5 7 7 8 6 6 7 8 25 11 23 12
65 38 41 7 5 5 6 6 8 6 6 6 7 22 10 26 10
63 65 60 8 9 9 9 8 8 9 9 9 9 25 12 25 15
73 62 65 9 9 9 9 9 8 8 8 8 24 18 24 16
85 40 43 8 5 5 5 7 9 7 7 8 8 25 14 22 9
75 45 46 7 4 4 5 5 7 5 5 6 6 27 13 23 18
82 50 60 9 7 7 7 9 8 7 7 7 8 26 12 28 15
57 35 32 7 4 4 4 6 8 6 6 7 7 24 11 23 16
66 40 43 8 5 5 5 6 7 5 5 6 6 28 11 21 9
54 25 32 6 4 4 4 5 6 5 5 5 6 25 13 19 11
81 47 64 9 7 7 7 9 8 7 7 7 8 26 12 24 13
89 60 58 8 6 6 6 7 8 6 6 7 7 28 12 26 16
74 42 47 6 4 4 5 5 7 5 5 6 6 22 12 26 12
63 55 7 8 8 8 8 8 8 8 8 8 24 20 25 21
65 33 37 6 4 4 4 5 7 5 6 6 6 27 19 26 21
85 50 55 7 4 4 4 5 7 6 6 6 7 26 12 29 11
63 58 60 6 7 7 6 6 8 8 8 8 8 34 14 28 16
78 75 70 7 7 7 7 7 8 8 8 8 8 22 11 20 9
66 31 36 8 5 6 6 7 8 6 7 7 7 29 12 29 14
64 42 44 7 5 5 6 6 8 6 7 7 7 23 11 24 10
74 48 55 7 5 5 6 6 8 7 7 8 8 30 14 32 18
61 37 40 7 5 5 5 6 7 5 5 5 6 25 11 24 11
58 55 54 8 9 9 8 8 8 8 8 8 8 32 27 30 20
72 68 70 9 9 9 9 9 8 7 7 8 8 15 12 21 15
67 40 45 7 5 5 5 6 8 6 6 6 7 24 10 26 13
Note: For the treatment assessments, only those patients who reported signiﬁcant outcome in the last assessment were followed up. Pre: pre-intervention, post: post-intervention, post-i:
immediately after intervention, post-1h: at one hour post intervention; post-1w: at one week post intervention; post-1m: at one month post intervention. Tinnitus loudness and distress
ranged 0–10 where 0 indicates the lowest level and 10 indicates the highest tolerable level.
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Table 4
The response variables for prior and post treatment for the sham tDCS.
THI Loudness Distress BDI BAI
Pre Post Post-1m Pre Post-i Post-1h Post-1w Post-1m Pre Post-i Post-1h Post-1w Post-1m Pre Post Pre Post
81 75 – 8 8 8 8 – 8 7 8 8 – 22 18 22 19
67 54 – 7 6 7 7 – 8 8 8 8 – 25 19 26 18
70 72 – 8 8 8 8 – 8 8 8 8 – 24 22 25 20
75 70 – 8 8 8 8 – 8 8 7 8 8 23 21 22 20
66 44 68 7 6 6 7 7 8 7 8 8 – 22 18 27 25
70 69 – 9 9 9 9 – 8 8 8 8 – 22 27 28 21
75 54 – 7 6 6 7 7 8 7 7 8 8 24 14 22 12
56 50 – 7 7 7 7 – 8 8 8 8 – 19 15 16 14
72 65 – 8 8 8 8 – 7 7 7 7 – 28 25 27 23
54 50 – 7 6 7 7 – 6 5 6 6 – 25 20 24 19
67 65 – 9 9 9 9 – 8 9 9 9 – 28 26 28 27
86 84 – 8 7 8 8 – 8 8 8 8 – 18 22 23 17
78 70 – 6 5 6 6 – 7 5 6 6 – 19 21 25 14
83 76 – 7 7 7 7 – 8 7 8 8 – 29 28 24 20
66 60 – 6 6 6 6 – 7 6 7 7 – 22 13 24 13
54 30 55 8 7 7 8 8 7 5 5 6 6 28 20 27 18
67 65 – 9 9 9 9 – 8 9 9 9 – 28 26 23 21
Note: For the treatment assessments, only those patients who reported signiﬁcant outcome in the last assessment were followed up. Post-i: immediately after intervention, post-1h: at one
hour post intervention; post-1w: at one week post intervention; post-1m: at one month post intervention. Tinnitus loudness and distress ranged 0–10 where 0 indicates the lowest level
and 10 indicates the highest tolerable level.
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A. Yadollahpour et al. / Data in Brief 15 (2017) 40–4646twice daily sessions (intersession interval of 6 hours) of 2 mA current for 20 min for 5 consecutive
days through 35 cm2 electrodes. The anode was placed over the right DLPFC (F4), and the cathode
over the left DLPFC (F3). In the sham group, the electrode montage was identical, but the device was
turned off after 30 s without the participant's knowledge. The THI was assessed pre and post inter-
vention, and at one month follow-up. Tinnitus loudness and distress were scored using a 0–10 rating
numerical visual analogue scale prior to intervention, and immediately, one hour, one week, and at
one month after the last stimulation session. Depression and anxiety scores were determined pre and
post intervention using the Beck Depression (BDI-II) and Anxiety Inventories (BAI). Moreover,
blinding quality of the study was assessed. During treatment, the patients were asked to remove all
metal-based jewelry from the head and neck.
2.4. Clinical evaluation
The tinnitus quality for each patient was determined through asking the patient and conﬁrmed by
the otolaryngologist/audiologist experts. The tinnitus was categorized as ringing, buzzing, hissing,
humming, ticking, high pitch whistling, thumping, cicadas, and pulsating.
The main measures or response variables included THI, tinnitus loudness and distress, and
depression and anxiety. The THI was assessed pre and post intervention, and at one-month follow-up.
Tinnitus loudness and distress were scored using a 0–10 rating numerical visual analogue scale (VAS)
prior to intervention, and immediately, one hour, one week, and at one month after the last stimu-
lation session. Depression and anxiety scores were determined pre and post intervention using the
BDI-II and BAI.Acknowledgements
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